| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/01/1999 | CN1044910C Indole derivatives |
| 09/01/1999 | CN1044909C 吲哚衍生物 Indole derivatives |
| 09/01/1999 | CN1044906C 3(2H)-pyridazinono derivatives, its preparing method and its composition |
| 09/01/1999 | CN1044905C Anellated dihydropyridines and its producing method and medicinal composition comprising them |
| 09/01/1999 | CN1044856C Medicine for homologous fructosan mixture producing process and use thereof |
| 08/31/1999 | USRE36288 Mixture of protein, lipid and carbohydrates |
| 08/31/1999 | US5945566 Central nervous system |
| 08/31/1999 | US5945539 Enzyme inhibitor |
| 08/31/1999 | US5945528 Efficient, simple process by forcing starch through high pressure precision disintegration valve causing homogenization |
| 08/31/1999 | US5945514 Mannose binding lectin bonded through hydrophylic high molecular weight chain to hydrophobic molecular weight chain; aerosols, creams, lotions for prophylactic use against human immunodeficiency viruses and others |
| 08/31/1999 | US5945510 Substantially pure zonulin, a physiological modulator of mammalian tight junctions |
| 08/31/1999 | US5945505 Human phospholemman-like protein |
| 08/31/1999 | US5945456 Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells |
| 08/31/1999 | US5945455 Amine and amidine containing compounds as weight reducing agents |
| 08/31/1999 | US5945454 2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives |
| 08/31/1999 | US5945452 Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity |
| 08/31/1999 | US5945448 Brain edema inhibitor |
| 08/31/1999 | US5945447 Shelf life |
| 08/31/1999 | US5945446 Process for preparing synthetic soil-extract materials and medicaments based thereon |
| 08/31/1999 | US5945443 Kappa agonist compounds and pharmaceutical formulations thereof |
| 08/31/1999 | US5945442 Amino ceramide-like compounds and therapeutic methods of use |
| 08/31/1999 | US5945441 Administering to promote hair germination |
| 08/31/1999 | US5945440 Indolocarbazole imides and the use thereof |
| 08/31/1999 | US5945439 Method for destroying or inhibiting growth of unwanted cells or tissues |
| 08/31/1999 | US5945435 Levobupivacaine and its use |
| 08/31/1999 | US5945433 Humans and veterinary science |
| 08/31/1999 | US5945426 Derivatives of pyrimidine for treating acute cerebrovascular disorders |
| 08/31/1999 | US5945425 Method of using (H+ /K+)ATPase inhibitors as antiviral agents |
| 08/31/1999 | US5945424 Administering before sleep, combination of levodopa/carbidopaand caffeine to reduce side effects |
| 08/31/1999 | US5945420 Immunopotentiating and infection protective agent and production thereof |
| 08/31/1999 | US5945419 Method for treating allergic rhinitis |
| 08/31/1999 | US5945417 Nervous system disorders |
| 08/31/1999 | US5945416 Method for treating pain |
| 08/31/1999 | US5945415 (R)-5-bromo-N-(1-ethyl-4-methylhexahydro-1H-1,4-diazepin-6-yl)-2-methoxy-6-methylamino-3-pyridinecarboxamide, process for producing the same and medicinal composition containing the same |
| 08/31/1999 | US5945414 Process for the preparation of new intermediates useful in the synthesis of cephalosporins |
| 08/31/1999 | US5945412 Methods and compositions for preventing and treating bone loss |
| 08/31/1999 | US5945411 Chemoprevention of metachronous adenomatous colorectal polyps |
| 08/31/1999 | US5945410 Administered to treat postmanopausal osteoporosis, low bone turnover osteoporosis, osteomalacia and renal osteodystrophy |
| 08/31/1999 | US5945409 Topical moisturizing composition and method |
| 08/31/1999 | US5945408 Hydroxyanidino derivatives useful as nitric oxide synthase inhibitors |
| 08/31/1999 | US5945407 Methods and compositions using butyrate esters of threitol |
| 08/31/1999 | US5945406 Anticancer agents; treatment for metastatic liver cancer, fungal infections, psoriasis; used in manufacture of drugsto prevent cell division |
| 08/31/1999 | US5945405 Crystal form O of clarithromycin |
| 08/31/1999 | US5945401 Polypeptides as antidiabetic agents |
| 08/31/1999 | US5945400 Nucleic acid-containing composition, preparation and use thereof |
| 08/31/1999 | US5945399 Administering to provide alleviation of adverse efects of or complications associated with the disease including mortality and complications or morbidities |
| 08/31/1999 | US5945398 In a hydrophilic carrier comprising propylene glycol,esterification product of vegetable oil triglyceride and polyalkalene glycol polyol and polyoxyethylene hydrogenated castor oil; free-flowing, clear, transparent |
| 08/31/1999 | US5945317 Isolated from fermentation cultures of nodulisporum species; for insecticides, nematocides, miticides |
| 08/31/1999 | US5945316 From optically active or racemic amino acids and 2-hydroxycarboxylic acids |
| 08/31/1999 | US5945315 Isolating compound from culture of gsv224 nostoc species; antiproliferative agent for drug resistant cells |
| 08/31/1999 | US5945302 Nucleotide sequences that code for proteins for use in recombinant technology, induce production of cytokines, activate cell differentiation, stimulate and suppress immune responses, and therapy for autoimmune diseases |
| 08/31/1999 | US5945129 Process for the production of an infusion or dialysis solution containing bicarbonate |
| 08/31/1999 | US5945125 Consists of a single homogenous mixture of a drug selected from nifedipine, diclofenac sodium, salicylic acid, theophylline anhydrous etc. and an excipient comprising polyethylene oxide and lubricant |
| 08/31/1999 | US5945124 Bactericide |
| 08/31/1999 | US5945123 Determining known pharacokinetic parameters of therapeutical substance, number of doses to be administered during 24 hours and determining time at which dose will be adminstered by considering both schedule and physiological anamolies |
| 08/31/1999 | US5945122 Liposomes containing a cisplatin compound |
| 08/31/1999 | US5945121 Liposome eye drops |
| 08/31/1999 | US5945117 Treatment of female sexual dysfunction |
| 08/31/1999 | US5945109 Cosmetic or cosmetic product for firming and smoothing the skin, in particular in the case of cellulite |
| 08/31/1999 | US5945100 Tumor delivery vehicles |
| 08/31/1999 | US5945089 Contacting the affected area of oral mucosa with an amount of a formulation containing triclosan |
| 08/31/1999 | US5945032 Bactericides, disinfectants, hair cosmetics |
| 08/31/1999 | US5944021 Therapeutic use of a carbonic anhydrase enzyme inhibitor for the treatment of brain edema |
| 08/31/1999 | US5944012 Dry powder with permeation promoter |
| 08/31/1999 | CA2175179C Non-aqueous emollient iodophor formulations |
| 08/31/1999 | CA2173328C Hiv protease inhibitors |
| 08/31/1999 | CA2173147C Anti-obesity agent |
| 08/31/1999 | CA2167382C Novel fused indan derivative and pharmaceutically acceptable salt thereof |
| 08/31/1999 | CA2163216C Anxiolytic agent |
| 08/31/1999 | CA2149765C Sequence-specific binding polymers for duplex nucleic acids |
| 08/31/1999 | CA2145835C Hydroxamic acid derivatives with tricyclic substitution |
| 08/31/1999 | CA2141765C Stabilized ascorbic acid containing emulsion; cosmetic treatment process using said emulsion and other uses |
| 08/31/1999 | CA2118030C Drug for increasing the level of testosterone in the body |
| 08/31/1999 | CA2075482C Sulfonanilide derivatives and medicine |
| 08/31/1999 | CA2069374C Synthesis of 19-nor vitamin d compounds |
| 08/31/1999 | CA2033447C Synergistic combination for treating herpes infections |
| 08/31/1999 | CA2007334C Anti-ulcer composition |
| 08/31/1999 | CA2006028C Cosmetic or pharmaceutical composition containing polymers or fatty bodies microspheres with at least one active ingredient |
| 08/31/1999 | CA2004364C Antisense oligonucleotides to c-myb oncogene and uses thereof |
| 08/27/1999 | CA2242794A1 2,4-bis[(4-aminidino)phenyl]furans as anti-pneumocystis carini agents |
| 08/26/1999 | WO1999042839A2 Treating cancer |
| 08/26/1999 | WO1999042837A1 Treating cancer |
| 08/26/1999 | WO1999042836A1 Treating cancer |
| 08/26/1999 | WO1999042835A1 Treating cancer |
| 08/26/1999 | WO1999042834A2 Treating cancer |
| 08/26/1999 | WO1999042828A2 Treating cancer |
| 08/26/1999 | WO1999042821A2 Treating cancer |
| 08/26/1999 | WO1999042617A1 Levo-monosaccharide in a nucleoside analog for use as an antiretroviral agent |
| 08/26/1999 | WO1999042603A1 GABAB-R2a, A 7TM RECEPTOR |
| 08/26/1999 | WO1999042602A2 Fermentative preparation process for cytostatics and crystal forms thereof |
| 08/26/1999 | WO1999042601A1 PROCESS FOR THE OBTAINING OF HMG-CoA REDUCTASE INHIBITORS OF HIGH PURITY |
| 08/26/1999 | WO1999042593A1 Compositions and methods for sensitizing and inhibiting growth of human tumor cells |
| 08/26/1999 | WO1999042574A1 Sequences of an ih ionic channel and the use thereof |
| 08/26/1999 | WO1999042501A2 Method for the production of polymers from n-vinyl compounds |
| 08/26/1999 | WO1999042465A2 Sulphonamide derivatives being 5-ht6 receptor antagonists and process for their preparation |
| 08/26/1999 | WO1999042458A1 Histamine h3 receptor ligands |
| 08/26/1999 | WO1999042456A2 Novel compounds and their use as positive ampa receptor modulators |
| 08/26/1999 | WO1999042453A1 5-substituted pyrimidine-2-yloxy carboxylic acid derivatives, the production of the same and their utilization as endothelin antagonists |
| 08/26/1999 | WO1999042452A1 Phthalazine derivatives and remedies for erectile dysfunction |
| 08/26/1999 | WO1999042448A1 Novel substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia |